LPCN Annual CFO
-$11.87 M
+$102.80 K+0.86%
31 December 2023
Summary:
As of January 23, 2025, LPCN annual cash flow from operations is -$11.87 million, with the most recent change of +$102.80 thousand (+0.86%) on December 31, 2023. During the last 3 years, it has risen by +$3.44 million (+22.46%). LPCN annual CFO is now -162447.95% below its all-time high of -$7300.00, reached on December 31, 2011.LPCN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPCN Quarterly CFO
-$2.83 M
-$335.10 K-13.42%
30 September 2024
Summary:
As of January 23, 2025, LPCN quarterly cash flow from operations is -$2.83 million, with the most recent change of -$335.10 thousand (-13.42%) on September 30, 2024. Over the past year, it has dropped by -$810.60 thousand (-40.08%). LPCN quarterly CFO is now -131.50% below its all-time high of $8.99 million, reached on December 31, 2021.LPCN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPCN TTM CFO
-$4.95 M
-$226.90 K-4.81%
30 September 2024
Summary:
As of January 23, 2025, LPCN TTM cash flow from operations is -$4.95 million, with the most recent change of -$226.90 thousand (-4.81%) on September 30, 2024. Over the past year, it has increased by +$6.92 million (+58.32%). LPCN TTM CFO is now -145355.88% below its all-time high of -$3400.00, reached on June 30, 2013.LPCN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPCN Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.9% | -40.1% | +58.3% |
| 3 y3 years | +22.5% | +14.4% | +59.7% |
| 5 y5 years | +1.8% | +14.4% | +59.7% |
LPCN Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -169.0% | +0.9% | -131.5% | +27.9% | -335.6% | +59.7% |
| 5 y | 5-year | -169.0% | +22.5% | -131.5% | +59.4% | -335.6% | +71.1% |
| alltime | all time | <-9999.0% | +35.1% | -131.5% | +63.0% | <-9999.0% | +75.5% |
Lipocine Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.83 M(+13.4%) | -$4.95 M(+4.8%) |
| June 2024 | - | -$2.50 M(-203.8%) | -$4.72 M(-14.7%) |
| Mar 2024 | - | $2.41 M(-219.0%) | -$5.53 M(-53.4%) |
| Dec 2023 | -$11.87 M(-0.9%) | -$2.02 M(-22.4%) | -$11.87 M(+1.6%) |
| Sept 2023 | - | -$2.61 M(-21.3%) | -$11.68 M(-4.8%) |
| June 2023 | - | -$3.31 M(-15.7%) | -$12.27 M(+2.2%) |
| Mar 2023 | - | -$3.93 M(+113.6%) | -$12.01 M(+0.4%) |
| Dec 2022 | -$11.97 M(+171.3%) | -$1.84 M(-42.5%) | -$11.97 M(+954.1%) |
| Sept 2022 | - | -$3.20 M(+5.0%) | -$1.14 M(-76.9%) |
| June 2022 | - | -$3.05 M(-21.6%) | -$4.92 M(+16.1%) |
| Mar 2022 | - | -$3.89 M(-143.2%) | -$4.24 M(-4.0%) |
| Dec 2021 | -$4.41 M(-71.2%) | $8.99 M(-228.8%) | -$4.41 M(-74.2%) |
| Sept 2021 | - | -$6.98 M(+195.4%) | -$17.09 M(+19.7%) |
| June 2021 | - | -$2.36 M(-41.8%) | -$14.27 M(-10.7%) |
| Mar 2021 | - | -$4.06 M(+10.3%) | -$15.99 M(+4.5%) |
| Dec 2020 | -$15.30 M(+31.2%) | -$3.68 M(-11.5%) | -$15.30 M(+2.5%) |
| Sept 2020 | - | -$4.16 M(+2.1%) | -$14.93 M(+10.1%) |
| June 2020 | - | -$4.08 M(+20.8%) | -$13.56 M(+12.6%) |
| Mar 2020 | - | -$3.38 M(+2.1%) | -$12.04 M(+3.2%) |
| Dec 2019 | -$11.67 M(-3.4%) | -$3.31 M(+18.3%) | -$11.67 M(+10.2%) |
| Sept 2019 | - | -$2.80 M(+9.4%) | -$10.59 M(-5.0%) |
| June 2019 | - | -$2.56 M(-14.8%) | -$11.15 M(-1.6%) |
| Mar 2019 | - | -$3.00 M(+34.5%) | -$11.34 M(-6.2%) |
| Dec 2018 | -$12.08 M | -$2.23 M(-33.5%) | -$12.08 M(-14.6%) |
| Sept 2018 | - | -$3.36 M(+22.6%) | -$14.14 M(-7.9%) |
| June 2018 | - | -$2.74 M(-26.9%) | -$15.35 M(-11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$3.75 M(-12.8%) | -$17.31 M(+3.6%) |
| Dec 2017 | -$16.70 M(-8.6%) | -$4.30 M(-5.9%) | -$16.70 M(+11.7%) |
| Sept 2017 | - | -$4.57 M(-2.9%) | -$14.95 M(+3.6%) |
| June 2017 | - | -$4.70 M(+49.8%) | -$14.44 M(-3.2%) |
| Mar 2017 | - | -$3.14 M(+23.2%) | -$14.91 M(-18.4%) |
| Dec 2016 | -$18.28 M(+19.1%) | -$2.55 M(-37.1%) | -$18.28 M(-2.0%) |
| Sept 2016 | - | -$4.05 M(-21.8%) | -$18.65 M(-7.5%) |
| June 2016 | - | -$5.18 M(-20.5%) | -$20.15 M(+7.0%) |
| Mar 2016 | - | -$6.51 M(+123.6%) | -$18.84 M(+22.7%) |
| Dec 2015 | -$15.36 M(-11.3%) | -$2.91 M(-47.6%) | -$15.36 M(-6.4%) |
| Sept 2015 | - | -$5.56 M(+43.9%) | -$16.41 M(+23.1%) |
| June 2015 | - | -$3.86 M(+27.6%) | -$13.33 M(-22.1%) |
| Mar 2015 | - | -$3.03 M(-23.7%) | -$17.11 M(-1.1%) |
| Dec 2014 | -$17.30 M(+101.5%) | -$3.96 M(+60.0%) | -$17.30 M(-0.9%) |
| Sept 2014 | - | -$2.48 M(-67.6%) | -$17.45 M(-10.3%) |
| June 2014 | - | -$7.65 M(+137.6%) | -$19.45 M(+64.8%) |
| Mar 2014 | - | -$3.22 M(-21.8%) | -$11.81 M(+37.5%) |
| Dec 2013 | -$8.59 M(>+9900.0%) | -$4.11 M(-8.1%) | -$8.59 M(+258.0%) |
| Sept 2013 | - | -$4.47 M(>+9900.0%) | -$2.40 M(>+9900.0%) |
| June 2013 | - | -$400.00(+300.0%) | -$3400.00(-94.1%) |
| Mar 2013 | - | -$100.00(-100.0%) | -$58.00 K(-7.9%) |
| Dec 2012 | -$62.90 K(+761.6%) | $2.08 M(-199.9%) | -$63.00 K(-97.1%) |
| Sept 2012 | - | -$2.08 M(+3679.8%) | -$2.14 M(+3459.1%) |
| June 2012 | - | -$55.00 K(+978.4%) | -$60.10 K(+1078.4%) |
| Mar 2012 | - | -$5100.00 | -$5100.00 |
| Dec 2011 | -$7300.00 | - | - |
FAQ
- What is Lipocine annual cash flow from operations?
- What is the all time high annual CFO for Lipocine?
- What is Lipocine annual CFO year-on-year change?
- What is Lipocine quarterly cash flow from operations?
- What is the all time high quarterly CFO for Lipocine?
- What is Lipocine quarterly CFO year-on-year change?
- What is Lipocine TTM cash flow from operations?
- What is the all time high TTM CFO for Lipocine?
- What is Lipocine TTM CFO year-on-year change?
What is Lipocine annual cash flow from operations?
The current annual CFO of LPCN is -$11.87 M
What is the all time high annual CFO for Lipocine?
Lipocine all-time high annual cash flow from operations is -$7300.00
What is Lipocine annual CFO year-on-year change?
Over the past year, LPCN annual cash flow from operations has changed by +$102.80 K (+0.86%)
What is Lipocine quarterly cash flow from operations?
The current quarterly CFO of LPCN is -$2.83 M
What is the all time high quarterly CFO for Lipocine?
Lipocine all-time high quarterly cash flow from operations is $8.99 M
What is Lipocine quarterly CFO year-on-year change?
Over the past year, LPCN quarterly cash flow from operations has changed by -$810.60 K (-40.08%)
What is Lipocine TTM cash flow from operations?
The current TTM CFO of LPCN is -$4.95 M
What is the all time high TTM CFO for Lipocine?
Lipocine all-time high TTM cash flow from operations is -$3400.00
What is Lipocine TTM CFO year-on-year change?
Over the past year, LPCN TTM cash flow from operations has changed by +$6.92 M (+58.32%)